Literature DB >> 11078105

Decline of language among women and men with Alzheimer's disease.

L E Hebert1, R S Wilson, D W Gilley, L A Beckett, P A Scherr, D A Bennett, D A Evans.   

Abstract

Previous research raises the possibility that gender differences occur in language function in Alzheimer's disease, but this hypothesis has not been evaluated systematically in longitudinal studies. The authors examined the association of gender with rate of decline in language and other cognitive functions among 410 persons with Alzheimer's disease. Participants were recruited from a dementia clinic and followed for up to 5 annual evaluations. Follow-up participation among survivors exceeded 90%. Decline in a composite score based on 8 language tests was evaluated in random effects models with age, education, and race controlled. Annual decline was 0.71 standard units (95% confidence interval [CI] = 0.62-0.79) for women and 0.74 units (95% CI = 0.61-0.86) for men, not a significant difference. Decline on the individual language tests and on composite measures of memory, perception, and global cognition also indicated no significant association with gender. These results suggest that Alzheimer's disease affects language and other cognitive functions similarly in women and men.

Entities:  

Mesh:

Year:  2000        PMID: 11078105     DOI: 10.1093/geronb/55.6.p354

Source DB:  PubMed          Journal:  J Gerontol B Psychol Sci Soc Sci        ISSN: 1079-5014            Impact factor:   4.077


  10 in total

1.  Sex differences in grey matter atrophy patterns among AD and aMCI patients: results from ADNI.

Authors:  Martha Skup; Hongtu Zhu; Yaping Wang; Kelly S Giovanello; Ja-an Lin; Dinggang Shen; Feng Shi; Wei Gao; Weili Lin; Yong Fan; Heping Zhang
Journal:  Neuroimage       Date:  2011-02-26       Impact factor: 6.556

2.  A random change point model for cognitive decline in Alzheimer's disease and mild cognitive impairment.

Authors:  Lei Yu; Patricia Boyle; Robert S Wilson; Eisuke Segawa; Sue Leurgans; Philip L De Jager; David A Bennett
Journal:  Neuroepidemiology       Date:  2012-07-17       Impact factor: 3.282

Review 3.  Sex differences in cognitive impairment in Alzheimer's disease.

Authors:  Keith R Laws; Karen Irvine; Tim M Gale
Journal:  World J Psychiatry       Date:  2016-03-22

4.  Cognitive decline in incident Alzheimer disease in a community population.

Authors:  R S Wilson; N T Aggarwal; L L Barnes; C F Mendes de Leon; L E Hebert; D A Evans
Journal:  Neurology       Date:  2010-03-23       Impact factor: 9.910

5.  Gender-specificities in Alzheimer's disease and mild cognitive impairment.

Authors:  U Beinhoff; H Tumani; J Brettschneider; D Bittner; M W Riepe
Journal:  J Neurol       Date:  2008-01-18       Impact factor: 4.849

6.  Executive decline and dysfunction precedes declines in memory: the Women's Health and Aging Study II.

Authors:  Michelle C Carlson; Qian-Li Xue; Jing Zhou; Linda P Fried
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-01-31       Impact factor: 6.053

Review 7.  Neuropsychological assessment in the diagnosis of Alzheimer's disease.

Authors:  Sharelle Baldwin; Sarah Tomaszewski Farias
Journal:  Curr Protoc Neurosci       Date:  2009-10

Review 8.  Role of neuroinflammation in adult neurogenesis and Alzheimer disease: therapeutic approaches.

Authors:  Almudena Fuster-Matanzo; María Llorens-Martín; Félix Hernández; Jesús Avila
Journal:  Mediators Inflamm       Date:  2013-04-03       Impact factor: 4.711

9.  Is there a relationship between accelerometer-assessed physical activity and sedentary behavior and cognitive function in US Hispanic/Latino adults? The Hispanic Community Health Study/Study of Latinos (HCHS/SOL).

Authors:  Elizabeth Vásquez; Garrett Strizich; Carmen R Isasi; Sandra E Echeverria; Daniela Sotres-Alvarez; Kelly R Evenson; Marc D Gellman; Priya Palta; Qibin Qi; Melissa Lamar; Wassim Tarraf; Hector M González; Robert Kaplan
Journal:  Prev Med       Date:  2017-07-29       Impact factor: 4.637

Review 10.  Curcumin: a natural substance with potential efficacy in Alzheimer's disease.

Authors:  Pamela E Potter
Journal:  J Exp Pharmacol       Date:  2013-05-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.